Seven Eight Capital’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-146,500
Closed -$1M 540
2017
Q3
$1M Buy
+146,500
New +$924K 0.12% 249
2017
Q1
Sell
-1
Closed 634
2016
Q4
$0 Buy
+1
New +$10 ﹤0.01% 627
2016
Q3
Sell
-8,008
Closed -$75K 493
2016
Q2
$75K Buy
8,008
+6,530
+442% +$66.3K 0.03% 419
2016
Q1
$15K Buy
1,478
+1,371
+1,281% +$12.5K 0.01% 485
2015
Q4
$1K Sell
107
-13,000
-99% -$130K ﹤0.01% 534
2015
Q3
$110K Sell
13,107
-30,400
-70% -$402K 0.1% 272
2015
Q2
$700K Buy
43,507
+40,707
+1,454% +$633K 0.83% 10
2015
Q1
$40K Buy
+2,800
New +$36.4K 0.07% 307
2014
Q2
Sell
-16,329
Closed -$152K 576
2014
Q1
$152K Buy
16,329
+1,803
+12% +$15.8K 0.13% 260
2013
Q4
$123K Buy
+14,526
New +$147K 0.14% 234

Other funds holding OPK

Seven Eight Capital's OPK Position: Q4 2017 in Review

Seven Eight Capital sold out of Opko Health (OPK) in Q4 2017, closing a stake of 146,500 shares — an estimated $1M sold.

Seven Eight Capital first reported a position in OPK in Q4 2013 and held it in 10 quarters. The position peaked at $1M in Q3 2017. 231 funds tracked by Wall St. Rank hold OPK as of Q4 2017.

  • Seven Eight Capital reported no remaining Opko Health position as of Q4 2017 after selling out during the quarter.
  • Seven Eight Capital sold 146,500 Opko Health shares in Q4 2017, an estimated $1M.
  • Seven Eight Capital first reported a position in Opko Health in Q4 2013 and held it in 10 quarters.
  • Seven Eight Capital's Opko Health position peaked at $1M in Q3 2017.
  • 231 funds tracked by Wall St. Rank held Opko Health as of Q4 2017.

Based on Seven Eight Capital's 13F filing for Q4 2017, filed 12 Feb 2018.